XNCR Q2 2025 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$44M+157.1% YoY

Gross Profit

$41M93.9% margin

Operating Income

-$33M-76.1% margin

Net Income

-$31M-70.7% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

+33.2%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$37M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$879M

Total Liabilities

$259M

Stockholders' Equity

$620M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$17M	+157.1%
Gross Profit	$41M	$14M	+193.9%
Operating Income	-$33M	-$62M	+46.8%
Net Income	-$31M	-$66M	+53.3%

Revenue Segments

Milestone

$25M57%

Royalty

$19M43%